A new series of 7-methoxy-2-[4-(t-amino-1-yl)oxy]-naphthalene derivatives; 7-methoxy-2-{[4-(2-methylpiperidine)but-2-
INTRODUCTION
The need for modern, safe and more effective antimicrobial agents are becoming an urgent need as many bacteria and fungi were becoming multi-antimicrobial resistant, due to unavoidable consequence of the widespread and misuse of the commonly available antimicrobial agents [1] [2] [3] [4] [5] [6] . Goksu et al. 2005 synthesized naphthalene derivatives 5-bromo-6methoxynapthalene-2-carboxylic acid and 5,6-dimethoxynapthalene-2-carboxylic acid (Figure 1 ), these derivatives showed in vitro antimicrobial activity against some types of bacteria 7 . Chakkaravarthi et al. 2014 , synthesized novel naphthalene derivative 1-[(3-hydroxy naphthalene-2-yl) methyl]Thioreau (figure 2), this derivative was screened as an antimicrobial agent on Staphylococcus aureus, Mycobacterium smegmatis, Pseudomonas aeruginosa, Candida albicans, Candida tropicalis and Candida glabrata. The synthesized compound showed better activity against tested microbial strains and significant anti-oxidant activities 8 . Aryloxy derivatives as antifungal agents as in tolnaftate or arylallylamine as naftifine 8 and many heterocyclic compounds [9] [10] [11] [12] [13] , promoted our interest to envision a new and novel series of aryloxyaminoacetylenic derivatives (RZ2-7) as potential antimicrobial agents with minimal resistant development. These new molecules provide the following interaction that inhibit various sites within microbial cells. Hydrogen bonding with ether oxygen. π-overlap with naphthyloxy group. Electrostatic interaction with acetylenic moiety and ionic interaction that provided by cyclic amine in addition to the appropriate distance between aryloxy and cyclic amine. The observed antifungal and antibacterial activity presented in 
7-methoxy-2-{[4-(t-amino-1-yl)but-2-yn-1-yl]oxy}-naphthalene by Mannich reaction (RZ2-7)
7-methoxy-2-(prop-2-yn-1-yloxy) naphthalene (RZ1) (2.12 g, 0.01 mole), Para formaldehyde (0.5 g, 0.015 mole), 0.01 molecyclic amine (1-methylpiperazine, 2-methyl piperidine, 2,6-dimethyl piperidine, azepane, pyrolidine, piperidine) and a catalytic amount of cuprous chloride (0.03g) in 30 ml dioxane were stirred and heated under reflux at 70-75 o C for three hours. The mixture was filtered and evaporated under reduced pressure. The final products were RZ2-7 as presented in figure 3 .
7-methoxy-2-{[4-(2-methylPiperidine)but-2-yn-1-yl]oxy}-naphthalene (RZ2)
RZ2 was synthesized using the procedure described for the synthesis of 7-methoxy 2{[4-(t-amino-1-yl)but-2-yn- 
7-methoxy-2-{[4-(N-methylPiperazine)but-2-yn-1-yl]oxy}-naphthalene (RZ6)
RZ6 was synthesized using the procedure described for the synthesis of 7-methoxy-2-{[4-(t-amino-1-yl)but-2-yn-1-yl]oxy}-naphthalene by Mannich reaction in 1.9g, yield (58.82%) and UV-HPLC retention time: 
7-methoxy-2-{[4-(Hexamethyleneimine)but-2-yn-1-yl]oxy}-naphthalene (RZ7)
RZ7 was synthesized using the procedure described for the synthesis of 7-methoxy -2-{[4-(t-amino-1-yl)but-2-yn-1-yl]oxy}-naphthalene by Mannich reaction in 1. 14 , the minimum bactericidal concentration (MBC) and minimum fungicidal concentration (MFC) were also recorded against the selected microorganisms. Stock solutions of the compounds were first prepared by dissolving them in a solution of 30% DMSO in water. Then the stock solutions were serially diluted in twofold dilutions in Muller Hinton broth (MHB) for bacteria and Sabourauds dextrose broth (SDA) for fungi), so as to achieve the required concentrations of the compound ranging from 500-7.875µg/ml. 0.1 ml of the overnight bacterial or fungal broth were added to each tube. Negative control tube contained tested compound dilution in sterile MHB/SDB while, positive control tube contained 0.1 ml of overnight culture and sterile MHB/SDB. The tubes were incubated at 37 O C for 24 hours for bacteria and 48 hours for fungi. Each concentration tube turbidity was compared with the positive control tube turbidity; MIC tube is the lowest concentration of the compound in which no turbidity was observed. MIC tube and the tubes with dilutions preceded were cultured onto MHA/SDA plates, the plates were incubated at 37 o C for 24 hours /48 hours for bacteria and fungi respectively. The minimum bactericidal concentrations (MBC) and fungicidal concentrations (MFC) were the lowest concentration of the compound Scheme 1: Alkylation reaction of 7-methoxy-2-naphthole.
Scheme 2: Mannich reaction proposed.
gave no growth 14 . The results of antimicrobial testing are reported and compared with those of the standard drugs (Ciprofloxacin 5 µg/ml and Fluconazole 500 µg/ml). Antimicrobial activity testing was performed in triplicates.
RESULTS AND DISCUSSION
Chemistry Compounds (RZ2-7) were synthesized as illustrated in (scheme 1 and scheme 2). Scheme 1 involves the alkylation of 7-methoxy-2-naphthole by addition propargyl bromide under basic conditions. This reaction generates phenolate anion that displaces the bromine on β-carbon of propargyl bromide afforded 7-methoxy-2-(prop-2-oxy)-naphthalene. In Mannich reaction Schiff base formation was generated from condensation of the formaldehyde with the cyclic amine, followed by dehydration. The attack of the acetylenic anion of the methoxy-2-(prop-2-yn-1-yloxy) on the carbon double bond of the Schiff base yielded the desired compounds (RZ2-7) as an outline in scheme 2.
Antimicrobial activity
The novel synthesized compounds (RZ2-7) showed antimicrobial activity against all types of the microorganisms tested (Table 1) . Compounds RZ4-7demonstrated the highest antimicrobial activity against E. coli with MIC value 125 µg/ml. CompoundsRZ2, RZ5, RZ6, RZ7 showed good antimicrobial activity against S. aureus with MIC value 62.5 µg/ml. Compound RZ2, RZ4, RZ5, RZ7 exerted antimicrobial activity against B. subtilis with MIC value 62.5 µg/ml. Compounds RZ2, RZ4, RZ5, RZ6, RZ7 showed antimicrobial activity against C. albicans with MIC value 62.5 µg/ml. All compounds exhibited antimicrobial activity against P. aeruginosa with MIC value 125 µg/ml. These results suggested that the newly synthesized compounds possess structural and electronic distribution that enable them to cross or penetrate the bacterial cells which are porins or lipid mediated pathway; this may be reflected in their activity against P. aeruginosa and E. coli. These compounds were also active against Gram positive bacteria (S. aureus and B. subtilis) were the peptidoglycan in Gram positive cells is more receptive to antimicrobial agent due to the absence of the outer membrane. Additionally the various electronic sites may interfere with various enzymes or sites in these microorganisms. In considering the differences in potency with the cyclic amine we recognize that the steric factors lower the potency as in comparing RZ3 with RZ5 and RZ2. The size of cyclic amine or the lipophilicity of similar compounds were influenced on potency in various compounds.
CONCLUSION
In conclusion, a unique aminoacetylenic derivative of naphthol provides an additional force of interaction with various microorganisms that showed good and promising activity against bacteria and fungi, and open a new area of investigation.
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